Skip to main content
  • Better Outcomes for Dedicated Severe Native AR TAVR Devices Vs Off-Label: Meta-Analysis

    Dedicated transcatheter aortic valve replacement (TAVR) devices led to better outcomes in high-risk severe native aortic regurgitation (AR) patients than off-label alternatives, according to a new meta-analysis in more than 2,000 patients. 

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details